1-4 of 4
free immunoglobulin light chain
Close
Sort by
Journal Articles

Utility of serum free light chain ratio in response definition in patients with multiple myeloma

Clinical Trials & Observations
Nadine Abdallah, Prashant Kapoor, David L. Murray, Francis K. Buadi, David Dingli, Angela Dispenzieri, Morie A. Gertz, Ronald S. Go, Wilson I. Gonsalves, Suzanne R. Hayman, Taxiarchis V. Kourelis, Martha Q. Lacy, Nelson Leung, John A. Lust, Eli Muchtar, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar
Journal: Blood Advances
Blood Adv (2020) 4 (2): 322–326.
https://doi.org/10.1182/bloodadvances.2019001099
Published: 2020
Journal Articles

Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone

Efstathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Maria Roussou, Nikolaos Kanellias, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Elektra Papadopoulou, Dimitrios C. Ziogas, Kimon Stamatelopoulos, Efstathios Manios, Argyrios Ntalianis, Evangelos Eleutherakis-Papaiakovou, Asimina Papanikolaou, Magdalini Migkou, Aristea-Maria Papanota, Harikleia Gakiopoulou, Erasmia Psimenou, Maria Irini Tselegkidi, Ourania Tsitsilonis, Ioannis Kostopoulos, Evangelos Terpos, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3002–3009.
https://doi.org/10.1182/bloodadvances.2019000147
Published: 2019
Includes: Supplemental data
Journal Articles

Wu V, Moshier E, Leng S, et al. Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling. Blood Adv . 2018;2(12):1470-1479.

Journal: Blood Advances
Blood Adv (2018) 2 (17): 2186.
https://doi.org/10.1182/bloodadvances.2018024281
Published: 2018
Journal Articles

Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling

Clinical Trials & Observations
Vernon Wu, Erin Moshier, Siyang Leng, Bart Barlogie, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Madhu Mazumdar, Samir Parekh, Ajai Chari
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1470–1479.
https://doi.org/10.1182/bloodadvances.2018016998
Published: 2018